Benefits
Exercise capacity: measured in humans, mostly no effect
Exercise capacity is the only performance outcome cordyceps has been tested for in healthy people, and the results are mostly negative. The largest trial (96 physical education students, 28 to 33 days) found no effect of a Cordyceps sinensis plus Ganoderma lucidum supplement on VO2max, peak power, mean power or fatigue index. Two reports on a Cs-4 plus Rhodiola formula in cyclists (17 and 8 men) found no effect on VO2, time to exhaustion, ventilatory threshold or muscle oxygen saturation. A 12-week pilot in 20 older adults taking 999 mg per day of Cs-4 raised metabolic and ventilatory thresholds within the treated group, but the between-group comparison was not significant and VO2max did not move. The one positive VO2max result used Cordyceps militaris inside a six-mushroom blend, and only in the 10 people (6 on the blend, 4 on placebo) who continued to 3 weeks. In the first week of that same study, the placebo group's VO2max rose more than the supplement group's. None of these studies used CordycepsPrime.
Daily energy and stamina: never measured in a trial
Cordyceps is a traditional tonic in Chinese medicine and is marketed as an adaptogenic energy ingredient. No randomized placebo-controlled trial has measured subjective energy, vitality or fatigue in healthy adults taking any cordyceps product. This claim rests on tradition and on marketing, not on a measurement.
Breathing: studied only in people with diagnosed lung disease
Traditional Chinese use of cordyceps for the lung is traditional use, not evidence. The human respiratory research that exists was done entirely in patients with diagnosed disease: a 48-week placebo-controlled trial of a Cordyceps sinensis capsule at 6 g per day in 238 people with chronic bronchitis, a 3-month controlled study in 120 people with moderate-to-severe asthma who were already on inhaled corticosteroids, and a meta-analysis of 15 studies in 1,238 people with stable COPD whose authors noted that no included study was placebo-controlled or of high methodological quality. None of that is a result in a healthy person, none of it used CordycepsPrime, and none of it is a reason for a healthy reader to take this product for breathing.
Recovery: one 14-person study of muscle repair markers
Some athletes use cordyceps during heavy training blocks. There is one human study: a randomized, double-blind, placebo-controlled crossover in 14 young adults given 1 g of Cordyceps sinensis or 1 g of cornstarch before high-intensity interval cycling. Muscle biopsies showed less necrotic cell infiltration 3 hours after exercise on cordyceps, earlier recruitment of CD34+ progenitor cells, and a four-fold expansion in Pax7+ cell count. Those are tissue repair markers read off a biopsy, not soreness, strength or training gains, and no trial has measured whether cordyceps improves recovery across a training block. None of it used CordycepsPrime.
Mechanism of action
Adenosine and mannitol (cordycepin is a C. militaris compound)
Cordycepin (3'-deoxyadenosine) is abundant in Cordyceps militaris and scarce in Cordyceps sinensis, so it is not the operative compound in a fermented C. sinensis mycelial extract like this one. What C. sinensis material carries is adenosine and D-mannitol, the compound the label calls cordycepic acid. Adenosine acts on adenosine receptors in laboratory work relevant to vasodilation and cellular energy metabolism. None of this has been shown to produce a measurable effect in people taking this ingredient.
Polysaccharide immunomodulation
Cordyceps polysaccharides are reported to engage innate immune receptors (similar to other fungal beta-glucans) and modulate cytokine production in animal and cell models, providing a mechanistic basis for traditional immune-supportive claims.
Mitochondrial bioenergetic support
Preclinical work suggests cordyceps constituents may support mitochondrial respiration and reduce exercise-induced oxidative stress, but the controlled human exercise trials that have been run were largely null, so this mechanism has not translated.
Clinical trials
Randomized, double-blind, placebo-controlled trial of PeakO2 (Compound Solutions), a 4 g/day blend of six mushroom mycelia cultured on organic oats: Cordyceps militaris, Ganoderma lucidum, Pleurotus eryngii, Lentinula edodes, Hericium erinaceus and Trametes versicolor. The Cordyceps militaris content of the blend was not disclosed. 28 participants completed the 1-week phase (13 blend, 15 placebo); 10 of them volunteered to continue to 3 weeks (6 blend, 4 placebo). Funded by Disruptive Nutrition, Burlington NC. Journal of Dietary Supplements 2017;14(1):42-53.
28 recreationally active adults at the 1-week timepoint (13 blend, 15 placebo); only 10 continued to the 3-week timepoint, split 6 on the blend and 4 on placebo, which is where the positive result appeared.
After 1 week there was no significant time by treatment interaction for VO2max (p = 0.364), ventilatory threshold (p = 0.514), time to exhaustion (p = 0.540), peak power (p = 0.134), average power (p = 0.398) or percent drop (p = 0.823), and the placebo group's VO2max actually rose more than the blend group's over that week. After 3 weeks, in the 10 people who continued (6 blend, 4 placebo), there was a significant time by treatment interaction for VO2max, which rose 4.8 mL/kg/min on the blend versus 0.9 on placebo (p = 0.042). Time to exhaustion showed no significant interaction at either 1 week (p = 0.540) or 3 weeks (p = 0.261); the reported gains came from a within-group 95 percent confidence interval analysis. This study used a different species (Cordyceps militaris), a different company's blend of six mushrooms rather than cordyceps alone, and 4 g/day against CordycepsPrime's 500 mg label. It does not transfer to this product.
This entry describes no study. A PubMed search and a Europe PMC search for the trade name CordycepsPrime each returned zero records, and NuLiv Science publishes no citation for the ingredient on its product page. The supplier's trade listings describe CordycepsPrime as clinically researched; no such research is publicly available.
None. No participants have ever been enrolled in a trial of this ingredient.
There are no findings. Anyone buying CordycepsPrime is buying a fermented Cordyceps sinensis mycelium extract that has never been tested in people. The cordyceps exercise trials that do exist in healthy adults have mostly reported no effect, and the positive human results for this species are on immune laboratory markers rather than on performance.